Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients

Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
A J RainbirdPatricia A Pellikka

Abstract

In this study we compared non-contrast imaging with contrast imaging of the left ventricle during dobutamine stress echocardiography (DSE). Wall segment visualization, image quality, and confidence of interpretation were determined with and without the use of intravenous Optison, a second-generation echocardiographic contrast agent, in 300 consecutive patients undergoing rest and peak DSE. At rest and at peak stress, the percentage of wall segments visualized, image quality, and confidence of interpretation were better with contrast compared with non-contrast imaging. No significant decrease was seen in wall segment visualization, image quality, or confidence of interpretation from rest to peak stress in images obtained with contrast, unlike the images obtained without contrast from rest to peak stress. The use of the intravenous echocardiographic contrast agent Optison during DSE significantly improved wall segment visualization and image quality at rest and at peak stress, resulting in improved confidence of interpretation.

Citations

Sep 28, 2001·Current Opinion in Cardiology·M Gunda, S L Mulvagh
Jul 10, 2003·Echocardiography·Navin C NandaUNKNOWN Imagent Clinical Investigators Group
Nov 6, 2008·Journal of the Cardiometabolic Syndrome·Daniel L WagnerRavi Rasalingam
Jan 10, 2009·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Roxy SeniorUNKNOWN RAMP-1 and RAMP-2 Investigators
Dec 25, 2009·Expert Review of Cardiovascular Therapy·Ronald MastouriJo Mahenthiran
Jan 19, 2012·Journal of Medical Systems·Adel LahsasnaAwang Bulgiba
Apr 29, 2015·Nature Reviews. Cardiology·Anita C BoydLiza Thomas
Jun 3, 2004·Nature Reviews. Drug Discovery·Jonathan R Lindner
Dec 18, 2004·The American Heart Hospital Journal·Jonathan R Lindner, Christopher Lewis
Oct 11, 2003·Echocardiography·Victor Mor-Avi, Roberto M Lang
Jun 28, 2006·Journal of Cardiovascular Medicine·Francesco GentileSarah Todd
Jan 12, 2010·Internal Medicine Journal·M HudaverdiD J Burstow
May 3, 2015·Cardiovascular Ultrasound·Eliza K UenishiWilson Mathias
Oct 14, 2014·Journal of cardiovascular ultrasound·Sang-Hoon Seol, Jonathan R Lindner
Sep 28, 2017·European Heart Journal Cardiovascular Imaging·Roxy SeniorUNKNOWN EACVI Scientific Documents Committee for 2014–16 and 2016–18
Oct 11, 2003·Echocardiography·Jeanne M DeCara, Roberto M Lang
Jun 26, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Ryotaro WakeMinoru Yoshiyama
Jun 27, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Ryotaro WakeJunichi Yoshikawa
Sep 26, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·N HeinickeA Luchner
May 1, 2008·Future Cardiology·James N Kirkpatrick, Martin G Keane
Jul 25, 2015·The International Journal of Cardiovascular Imaging·Arend F L SchinkelDaniel Staub
Aug 28, 2004·Cardiovascular Ultrasound·Stuart Moir, Thomas H Marwick
Apr 21, 2007·Critical Care Medicine·Kevin Wei, Jonathan Lindner
Oct 3, 2006·Clinical Cardiology·Roberto M Lang, Victor Mor-Avi
Nov 1, 2012·Australasian Journal of Ultrasound in Medicine·Rebecca Perry, Majo Joseph
Feb 25, 2009·Expert Opinion on Drug Safety·Michael L MainPaul A Grayburn
Mar 25, 2011·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Nowell M Fine, Patricia A Pellikka
Mar 9, 2021·Science China. Chemistry·Chen ZhangZhe Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.